Vaccine compositions and method for induction of mucosal...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 31/07 (2006.01) A61K 31/20 (2006.01) A61K 31/56 (2006.01) A61K 31/59 (2006.01) A61K 31/66 (2006.01) A61K 31/70 (2006.01) A61K 39/00 (2006.01) A61K 39/02 (2006.01) A61K 39/12 (2006.01)

Patent

CA 2153794

The invention relates to a vaccine which comprises an antigen and a lymphoid organ modifying agent. Suitable lymphoid organ modifying agents include, but are not limited to, 1,25-dihydroxy Vitamin D3, and Vitamin D3 derivatives which are capable of activating the intracellular Vitamin D3 receptor, all trans-retinoic acid, retinoic acid derivatives, retinol, retinol derivatives and glucocorticoid. The vaccine composition may further comprise an immune response aumenting agent. The immune response augmenting agent enhances T cell lymphokine production. Suitable immune response augmenting agents include, but are not limited to, DHEA and DHEA-derivatives. Examples of DHEA derivatives include DHEA-sulfate (DHEA-S),16-.alpha.-bromo-DHEA, 7-oxo-DHEA, 16-.alpha.bromo-DHEA-S, and 7-oxo- DHEA-S.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccine compositions and method for induction of mucosal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine compositions and method for induction of mucosal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine compositions and method for induction of mucosal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2013071

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.